CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Total revenues	$ 46,023	$ 11,369
Cost of goods sold:
Total cost of goods sold	7,128	1,537
Operating expenses:
Research and development	10,579	9,093
Selling, general and administrative	52,994	26,803
Total operating expenses	63,573	35,896
Loss from operations	(24,678)	(26,064)
Interest expense	(2,356)	(1,028)
Non-cash interest expense related to the sale of future royalties	(1,702)	(969)
Other income, net	2,339	1,302
Loss before provision for income taxes	(26,397)	(26,759)
Provision for income taxes	121	14
Net loss	$ (26,518)	$ (26,773)
Net loss per share of common stock - basic (in dollars per share)	$ (0.11)	$ (0.13)
Net loss per share of common stock - diluted (in dollars per share)	$ (0.11)	$ (0.13)
Shares used in computing net loss per share - basic (in shares)	233,065,960	207,023,127
Shares used in computing net loss per share - diluted (in shares)	233,065,960	207,023,127
Comprehensive loss:
Net loss	$ (26,518)	$ (26,773)
Unrealized (losses) gains on available-for-sale securities	(244)	34
Comprehensive loss	(26,762)	(26,739)
Product sales, net
Revenues:
Total revenues	43,512	11,355
Cost of goods sold:
Total cost of goods sold	1,013	372
Product supply revenue
Revenues:
Total revenues	2,126	2
Licensing revenue
Revenues:
Total revenues	17	12
Non-cash royalty revenue related to the sale of future royalties
Revenues:
Total revenues	368	0
Other cost of revenue
Cost of goods sold:
Total cost of goods sold	$ 6,115	$ 1,165